NCT06191939Completed
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
Source: ClinicalTrials.gov · Last updated 13 Apr 2026
Brief summary (registry, in English)
The goal of this pilot clinical trial is to test a disease-tailored, mindfulness-based intervention (Mindful Self-Compassion for Lung Cancer; MSC-LC) in adults diagnosed with lung cancer who are experiencing stigma. The current project seeks to: * Evaluate preliminary evidence for the feasibility, acceptability, and preliminary efficacy of MSC-LC in reducing stigma for adults with lung cancer, compared to a waitlist control condition * Elicit interventional impact not captured through quantitative measures with qualitative data from purposively sampled high responders and non-responders from the intervention condition Participants will randomized to either the MSC-LC intervention (a 10-week, virtually-delivered, group-based psychosocial intervention focused on the development of mindfulness and self-compassion skills) or to a waitlist control group that receives a referral to an NCI list of helpful mental health resources in their community. Researchers will compare the intervention and control groups to see if the MSC-LC intervention reduces lung cancer stigma and increases self-compassion.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 79 (actual)
- First submitted
- 20 Dec 2023
- Start date
- 6 May 2024
- Primary completion date
- 22 Jan 2026
- Lead sponsor
- Loyola Marymount University
- Diseases
- Lung cancer
- NCT number
- NCT06191939
What you commit to
- Study type: Interventional
- Participants enrolled: 79
- From 6 May 2024 to the primary completion date, 22 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Use of antidepressant, anxiolytic, antipsychotic, or mood stabilizing medication(s) for which the dose has been initiated or changed within the 8 weeks prior to study entry
Other
- Inability to understand study procedures or informed consent process, or significant personality dysfunction likely to interfere with study participation, as per study clinician's judgment
- Completed a course of Mindful Self-Compassion or an equivalent meditation training in the last year
Who the study is looking for
- Is at least 18 years of age as per self report;
- Has a confirmed lung cancer diagnosis, as per self-report and confirmed by clinician judgment or medical record note;
- Endorses elevated levels of lung cancer stigma (scores \>37.5 on the Lung Cancer Stigma Inventory)
- Able to read and respond to questions in English
Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Loyola Marymount University Coordinator of this site? Confirm its status | Los Angeles | United States | Unknown status |
Related publications
- Mindful self-compassion to reduce stigma among individuals diagnosed with lung cancer (MSC-LC): a pilot study protocol for a parallel-group, randomized controlled trial.Pilot Feasibility Stud · 2026 · PMID 41862990
This page is information, not medical advice. Discuss any trial with your doctor.